M&T Bank Corp Boosts Holdings in Encompass Health Co. (NYSE:EHC)

M&T Bank Corp raised its holdings in Encompass Health Co. (NYSE:EHC) by 26.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,910 shares of the company’s stock after purchasing an additional 823 shares during the period. M&T Bank Corp’s holdings in Encompass Health were worth $378,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Envestnet Portfolio Solutions Inc. increased its position in Encompass Health by 13.5% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 7,276 shares of the company’s stock worth $624,000 after purchasing an additional 866 shares in the last quarter. Raymond James & Associates grew its holdings in shares of Encompass Health by 7.8% during the second quarter. Raymond James & Associates now owns 134,638 shares of the company’s stock worth $11,551,000 after buying an additional 9,701 shares in the last quarter. Fifth Third Bancorp raised its position in shares of Encompass Health by 46.3% in the second quarter. Fifth Third Bancorp now owns 2,453 shares of the company’s stock valued at $210,000 after buying an additional 776 shares during the last quarter. Fifth Third Wealth Advisors LLC purchased a new position in shares of Encompass Health during the second quarter valued at approximately $262,000. Finally, Family Firm Inc. boosted its position in Encompass Health by 23.6% during the second quarter. Family Firm Inc. now owns 32,434 shares of the company’s stock worth $2,783,000 after acquiring an additional 6,202 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Barclays lifted their price target on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. KeyCorp increased their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, UBS Group boosted their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Price Performance

Encompass Health stock opened at $94.31 on Thursday. The firm has a fifty day moving average of $99.49 and a 200-day moving average of $92.78. Encompass Health Co. has a 52-week low of $65.80 and a 52-week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $9.50 billion, a P/E ratio of 22.78, a PEG ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.86 EPS. As a group, analysts predict that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is presently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.